Study of the Causes of the Breakdown of Muscle Fibers in Hospitalized Patients
NCT ID: NCT01022450
Last Updated: 2009-12-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
2500 participants
OBSERVATIONAL
2009-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
2. Analyze the characteristics of these patients in Taiwan (including the drugs history, risk factors and the incidence of complications).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Association Between Skeletal Muscle Mass and Severity of Polycystic Liver Disease and Polycystic Kidney Disease
NCT05215964
Association of Uremic Sarcopenia and Mitochondrial Copy Number and Its Clinical Correlates
NCT03929458
Sarcopenia Studies for the Elderly Population in Taiwan
NCT00174135
The Association of Genetic Polymorphisms With Statin-Induced Myopathy.
NCT00549029
Muscle Response to Enzyme Replacement Therapy in Pompe Disease
NCT00713453
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* especially drug-related
2. Find the risk factors of muscle fibers breakdown.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Taiwan University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Graduate Institute of Clinical Pharmacy, College of Medicine, National Taiwan University
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Fe-Lin L Wu, MSCP, PhD
Role: PRINCIPAL_INVESTIGATOR
Graduate Institute of Clinical Pharmacy, National Taiwan University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Taiwan University Hospital
Taipei, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
200911033R
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.